A specific approach for elderly patients with head and neck cancer

Anti-Cancer Drugs

Volumn 22, Issue 7, 2011, Pages 647-655

  Ortholan, Cécile ^a   Benezery, Karen ^b   Dassonville, Olivier ^b   Poissonnet, Gilles ^b   Bozec, Alexandre ^b   Guiochet, Nicole ^a   Belkacemi, Yazid ^a,c  

^a Centre Hospitalier Princesse Grace   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c Association of Radiotherapy and Oncology   (France)

Author keywords

geriatric oncology; head and neck cancer; old patients radiotherapy; surgery

Indexed keywords

ANTINEOPLASTIC AGENT; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TOBACCO SMOKE; VASCULOTROPIN RECEPTOR;

CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DERMATITIS; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; DYSPHAGIA; EVIDENCE BASED PRACTICE; FOLLOW UP; GERIATRIC ASSESSMENT; GERIATRIC PATIENT; HEAD AND NECK CANCER; HUMAN; MALNUTRITION; META ANALYSIS (TOPIC); MOUTH CANCER; MUCOSA INFLAMMATION; NECK DISSECTION; NUTRITIONAL SUPPORT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RETROSPECTIVE STUDY; REVIEW; TUMOR LOCALIZATION; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; HEAD AND NECK NEOPLASMS; HUMANS; MALNUTRITION; NUTRITIONAL SUPPORT; PRACTICE GUIDELINES AS TOPIC;

EID: 79960440863     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328344282a     Document Type: Review

References (68)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Jun MY, Strong EW, Saltzman EI, Gerold FP. Head and neck cancer in the elderly. Head Neck Surg 1983; 5:376-382. (Pubitemid 13060665)
3. Lampe HB, Lampe KM, Skillings J. Head and neck cancer in the elderly. J Otolaryngol 1986; 15:235-238. (Pubitemid 16077714)
4. Koch WM, Patel H, Brennan J, Boyle JO, Sidransky D. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg 1995; 121:262-265.
5. Chin R, Fisher RJ, Smee RI, Barton MB. Oropharyngeal cancer in the elderly. Int J Radiat Oncol Biol Phys 1995; 32:1007-1016.
6. Reid BC, Alberg AJ, Klassen AC, Samet JM, Rozier RG, Garcia I, Winn DM. Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001; 92:2109-2116. (Pubitemid 32973321)
7. Sarini J, Fournier C, Lefebvre JL, Bonafos G, Van JT, Coche-Dequéant B. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 2001; 127:1089-1092.
8. Vaccher E, Talamini R, Franchin G, Tirelli U, Barzan L. Elderly head and neck (HN) cancer patients: a monoinstitutional series. Tumori 2002; 88:63-66.
9. Sesterhenn AM, Teymoortash A, Folz BJ, Werner JA. Head and neck cancer in the elderly: a cohort study in 40 patients. Acta Oncol 2005; 44:59-64. (Pubitemid 40249129)
10. Cinamon U, Hier MP, Black MJ. Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? J Otolaryngol 2006; 35:8-12.
11. Lusinchi A, Bourhis J, Wibault P, Le Ridant AM, Eschwege F. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Oncol Biol Phys 1990; 18:819-823. (Pubitemid 20154039)
12. Clayman GL, Eicher SA, Sicard MW, Razmpa E, Goepfert H. Surgical outcomes in head and neck cancer patients 80 years of age and older. Head Neck 1998; 20:216-223. (Pubitemid 28169733)
13. Ortholan C, Lusinchi A, Italiano A, Bensadoun RJ, Auperin A, Poissonnet G, et al. Oral cavity squamous cell carcinoma in 260 patients aged 80 years or more. Radiother Oncol 2009; 93:516-523.
14. Italiano A, Ortholan C, Dassonville O, Poissonnet G, Thariat J, Benezery K, et al. Head and neck squamous cell carcinoma in patients aged Z 80 years: patterns of care and survival. Cancer 2008; 113:3160-3168.
15. Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17346 patients. Radiother Oncol 2009; 92:4-14.
16. Kruse AL, Bredell M, Luebbers HT, Grätz KW. Head and neck cancer in the elderly: a retrospective study over 10 years (1999-2008). Head Neck Oncol 2010; 2:25.
17. Jovanovic A, Schulten EA, Kostense PJ, Snow GB, Van der Waal I. Squamous cell carcinoma of the lip and oral cavity in The Netherlands: an epidemiological study of 740 patients. J Craniomaxillofac Surg 1993; 21:149-152. (Pubitemid 23209428)
18. Jovanovic A, Schulten EA, Kostense PJ, Snow GB, Van der Waal I. Tobacco and alcohol related to the anatomical site of oral squamous cell carcinoma. J Oral Pathol Med 1993; 22:459-462. (Pubitemid 2022697)
19. Carvalho AL, Singh B, Spiro RH, Kowalski LP, Shah JP. Cancer of the oral cavity: a comparison between institutions in a developing and a developed nation. Head Neck 2004; 26:31-38. (Pubitemid 38030147)
20. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24-35.
21. Buffa FM, Bentzen SM, Daley FM, Dische S, Saunders MI, Richman PI, et al. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Clin Cancer Res 2004; 10:3745-3754. (Pubitemid 38697608)
22. Suwinski R, Jaworska M, Nikiel B, Grzegorz W, Bankowska-Wozniak M, Wojciech M, et al. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial. Int J Radiat Oncol Biol Phys 2010; 77:438-446.
23. Extermann M, Aapro M, Bernabei R, Cohen HJ, Droz JP, Lichtman S, et al.; Task Force on CGA of the International Society of Geriatric Oncology. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55:241-252. (Pubitemid 41219694)
24. Bernabei R, Venturiero V, Tarsitani P, Gambassi G. The comprehensive geriatric assessment: when, where, how. Crit Rev Oncol Hematol 2000; 33:45-56. (Pubitemid 30064484)
25. Chäibi P, Magné N, Breton S, Chebib A, Watson S, Duron JJ, et al. Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol 2010 [Epub ahead of print].
26. Syrigos KN, Karachalios D, Karapanagiotou EM, Nutting CM, Manolopoulos L, Harrington KJ. Head and neck cancer in the elderly: an overview on the treatment modalities. Cancer Treat Rev 2009; 35:237-245.
27. Metges JP, Eschwcege F, de Crevoisier R, Lusinchi A, Bourhis J, Wibault P. Radiotherapy in head and neck cancer in the elderly: a challenge. Crit Rev Oncol Hematol 2000; 34:195-203. (Pubitemid 30320964)
28. Lalami Y, de Castro G Jr, Bernard-Marty C, Awada A. Management of head and neck cancer in elderly patients. Drugs Aging 2009; 26:571-583.
29. Luciani A, Ascione G, Bertuzzi C, Marussi D, Codecà C, Di Maria G, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 2010; 28:2046-2050.
30. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000; 5:224-237. (Pubitemid 30429942)
31. Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer 2010; 102:966-971.
32. Roh JL, Kim DH, Kim SY, Park CI. Quality of life and voice in patients after laser cordectomy for Tis and T1 glottic carcinomas. Head Neck 2007; 29:1010-1016.
33. Cosmidis A, Rame JP, Dassonville O, Temam S, Massip F, Poissonnet G, et al. T1-T2 N0 oropharyngeal cancers treated with surgery alone: a GETTEC study. Eur Arch Otorhinolaryngol 2004; 261:276-281. (Pubitemid 38680326)
34. Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999; 21:517-525. (Pubitemid 29415156)
35. Keski-Säntti H, Atula T, Törnwall J, Koivunen P, Mäkitie A. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 2006; 42:96-101. (Pubitemid 41831529)
36. Pernot M, Verhaeghe JL, Guillemin F, Carolus JM, Hoffstetter S, Peiffert D. Evaluation of the importance of systematic neck dissection in carcinoma of the oral cavity treated by brachytherapy alone for the primary lesion (apropos of a series of 346 patients). Bull Cancer Radiother 1995; 82:311-317.
37. Boruk M, Chernobilsky B, Rosenfeld RM, Har-El G. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg 2005; 131:605-609. (Pubitemid 41058050)
38. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005; 131:27-32. (Pubitemid 40105457)
39. Zabrodsky M, Calabrese L, Tosoni A, Ansarin M, Giugliano G, Bruschini R, et al. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol 2004; 13:249-255. (Pubitemid 40029622)
40. Peters TT, Van der Laan BF, Plaat BE, Wedman J, Langendijk JA, Halmos GB. The impact of comorbidity on treatment-related side effects in older pa¬tients with laryngeal cancer. Oral Oncol 2010; 47:56-61.
41. Teymoortash A, Wulf H, Werner JA. Head and neck cancer surgery in the elderly. Laryngorhinootologie 2002; 81:293-298. (Pubitemid 34475546)
42. Laccourreye O, Brasnu D, Perie S, Muscatello L, Menard M, Weinstein G. Supracricoid partial laryngectomies in the elderly: mortality, complications, and functional outcome. Laryngoscope 1998; 108:237-242. (Pubitemid 28128214)
43. Morgan RF, Hirata RM, Jaques DA, Hoopes JE. Head and neck surgery in the aged. Am J Surg 1982; 144:449-451. (Pubitemid 12037518)
44. Audisio RA, Pope D, Ramesh HS, Gennari R, Van Leeuwen BL, West C, et al.; PACE Participants. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help: a SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008; 65:156-163.
45. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48:7-16. (Pubitemid 30488207)
46. Hansen O, Overgaard J, Hansen HS, Overgaard M, Höyer M, Jörgensen KE, et al. Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation. Radiother Oncol 1997; 43:47-51. (Pubitemid 27191978)
47. Glatstein E. Hypofractionation, long-term effects, and the alpha/beta ratio. Int J Radiat Oncol Biol Phys 2008; 72:11-12.
48. Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006; 79:15-20.
49. Patel S, Wolff PB, Lin B, Karnad AB. Concurrent chemotherapy plus radiation therapy (CRT) in elderly patients (E): a retrospective analysis (abstract e19660). J Clin Oncol 2010; 28S.
50. Mohanti BK, Umapathy H, Bahadur S, Thakar A, Pathy S. Short-course palliative radiotherapy of 20Gy in 5 fractions for advanced and in¬curable head and neck cancer: AIIMS study. Radiother Oncol 2004; 71:275-280. (Pubitemid 38686664)
51. Porceddu SV, Rosser B, Burmeister BH, Jones M, Hickey B, Baumann K, et al. Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment: 'hypo irial'. Radiother Oncol 2007; 85:456-462. (Pubitemid 350218176)
52. Corry J, Peters LJ, Costa ID, Milner AD, Fawns H, Rischin D, et al. The 'QUAD SHOT': a phase II study of palliative radiotherapy for incurable head and neck cancer. Radiother Oncol 2005; 77:137-142. (Pubitemid 41682378)
53. Al-mamgani A, Tans L, Van rooij PH, Noever I, Baatenburg de jong RJ, Levendag PC. Hypofractionated radiotherapy denoted as the 'Christie scheme': an effective means of palliating patients with head and neck cancers not suitable for curative treatment. Acta Oncol 2009; 48:562-570.
54. Wasil T, Lichtman SM, Gupta V, Rush S. Radiation therapy in cancer patients 80 years of age and older. Am J Clin Oncol 2000; 23:526-530. (Pubitemid 32429134)
55. Russo G, Haddad R, Posner M, Machtay M. Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist 2008; 13:886-898.
56. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66:253-262. (Pubitemid 36556043)
57. Robertson C, Robertson AG, Hendry JH, Roberts SA, Slevin NJ, Duncan WB, et al. Similar decreases in local tumor control are calculated for treat¬ ment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 1998; 40:319-329. (Pubitemid 28114375)
58. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003; 362:933-940. (Pubitemid 37159288)
59. Cellai E, Frata P, Magrini SM, Paiar F, Barca R, Fondelli S, et al. Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease. Int J Radiat Oncol Biol Phys 2005; 63:1378-1386. (Pubitemid 41628032)
60. Pignon T, Horiot JC, Van den Bogaert W, Van Glabbeke M, Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 1996; 32:2075-2081. (Pubitemid 26419456)
61. Junor EJ, Macbeth FR, Barrett A. An audit of travel and waiting times for outpatient radiotherapy. Clin Oncol (R Coll Radiol) 1992; 4:174-176.
62. Charlton KE, Nichols C, Bowden S, Lambert K, Barone L, Mason M, et al. Older rehabilitation patients are at high risk of malnutrition: evidence from a large Australian database. J Nutr Health Aging 2010; 14:622-628.
63. Guo CB, Ma DQ, Zhang KH, Hu XH. Relation between nutritional state and postoperative complications in patients with oral and maxillofacial malignancy. Br J Oral Maxillofac Surg 2007; 45:467-470.
64. Ravasco P, Monteiro-Grillo I, Marques Vidal P, Camilo ME. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005; 27:659-668. (Pubitemid 41113766)
65. Paccagnella A, Morello M, Da Mosto MC, Baruffi C, Marcon ML, Gava A, et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer 2010; 18:837-845.
66. Salas S, Baumstarck-Barrau K, Alfonsi M, Digue L, Bagarry D, Feham N, et al. Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: prospective randomized trial. Radiother Oncol 2009; 93:503-509.
67. Chen AM, Li BQ, Lau DH, Farwell DG, Luu Q, Stuart K, et al. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2010; 78:1026-1032.
68. Lee H, Havrila C, Bravo V, Shantz K, Diaz K, Larner J, et al. Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 2008; 16:285-289. (Pubitemid 351422801)